Andere Sprachen Dicot AB

Aktien

Schlusskurs NORDIC GROWTH MARKET Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
0,2495 ^SEK	+4,83 %		+19,09 %	-21,54 %

23.04.	Dicot AB (publ) gibt positive Ergebnisse zur Sicherheit und verbesserten Wirksamkeit aus Phase 1-Studie bekannt	CI
11.03.	Dicot AB (publ) gibt den Abschluss der Rekrutierung für die Phase 1-Studie von Dicot bekannt	CI

Good safety and improved erectile function reported from Dicot's phase 1 study	23.04.
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	23.04.
Dicot in preparation for clinical phase 2a trial	12.04.
Reporting from Dicot's phase 1 study end of April	05.04.
BioStock: Dicot's phase I study fully recruited	14.03.
Recruitment completed in Dicot's phase 1 trial	11.03.
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	11.03.
Dicot's CEO tells BioStock: "Several prominent people want to be part of the journey"	29.02.
Dicot AB Year-End Report 2023	26.02.
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26.02.
BioStock: Good safety profile for Dicot's LIB-01	26.01.
Positive results from the first part of Dicot's phase 1 study	23.01.
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	23.01.
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	11.01.
Dicot applies for patent covering new manufacturing technology	11.01.
Dicot Applies for Patent Covering New Manufacturing Technology	11.01.
Dicot invited to present at ESSM for the third time	05.01.
BioStock: Interim results from Dicot's phase I study to be released earlier than expected	20.12.
Partial results from Dicot's phase 1 trial to be presented early next year	15.12.
Dicot AB Announces Partial Results from Phase 1 Trial to Be Presented Early Next Year	15.12.

Keine Ergebnisse zu dieser Suche